U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07213765) titled 'Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease' on July 19.
Brief Summary: The goal of this clinical trial is to learn if adding contezolid works to shorten the length of treatment in mycobacterium avium pulmonary disease in adults. It will also learn about the safety of extended usage of contezolid. The main questions it aims to answer are:
Does adding contezolid to standard regimen decrease the bacterial load, lesion severity and improve the life quality of patients with mycobacterium avium pulmonary disease? What medical problems do participants have when taking contezolid for an extended length? ...